Meg Doherty

11.6k total citations · 3 hit papers
121 papers, 6.8k citations indexed

About

Meg Doherty is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Meg Doherty has authored 121 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Infectious Diseases, 54 papers in Epidemiology and 41 papers in Virology. Recurrent topics in Meg Doherty's work include HIV/AIDS Research and Interventions (96 papers), HIV/AIDS drug development and treatment (42 papers) and HIV Research and Treatment (40 papers). Meg Doherty is often cited by papers focused on HIV/AIDS Research and Interventions (96 papers), HIV/AIDS drug development and treatment (42 papers) and HIV Research and Treatment (40 papers). Meg Doherty collaborates with scholars based in Switzerland, United States and United Kingdom. Meg Doherty's co-authors include David Vlahov, Marco Vitória, Nathan Ford, Kenrad E. Nelson, Richard S. Garfein, Noya Galai, Edward J. Mills, Richard S. Garfein, Zara Shubber and Sabin Nsanzimana and has published in prestigious journals such as JAMA, Nature Communications and PLoS ONE.

In The Last Decade

Meg Doherty

113 papers receiving 6.6k citations

Hit Papers

Viral infections in short... 1996 2026 2006 2016 1996 2004 2016 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.
    1996 581 citations David Vlahov, Meg Doherty et al. profile →
  2. Severe Community-Onset Pneumonia in Healthy Adults Caused by Methicillin-Resistant Staphylococcus aureus Carrying the Panton-Valentine Leukocidin Genes
    2004 560 citations Meg Doherty et al. profile →
  3. Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis
    2016 353 citations Zara Shubber, Edward J. Mills et al. PLoS Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Meg Doherty 4.9k 3.5k 1.4k 1.1k 908 121 6.8k
Bruce R. Schackman 3.3k 0.7× 3.4k 1.0× 1.5k 1.1× 940 0.9× 1.8k 2.0× 199 6.9k
Gregory M. Lucas 4.5k 0.9× 3.1k 0.9× 1.6k 1.2× 538 0.5× 630 0.7× 149 6.1k
Kelly A. Gebo 5.0k 1.0× 4.2k 1.2× 1.8k 1.3× 1.0k 0.9× 483 0.5× 185 7.8k
Carlo Giaquinto 5.4k 1.1× 2.6k 0.7× 2.4k 1.7× 664 0.6× 632 0.7× 360 9.5k
Alison D. Grant 5.7k 1.2× 4.0k 1.1× 1.1k 0.8× 843 0.8× 503 0.6× 218 7.4k
Nathan Ford 4.0k 0.8× 2.4k 0.7× 1.2k 0.9× 888 0.8× 418 0.5× 117 5.4k
Eli S. Rosenberg 6.1k 1.2× 4.3k 1.2× 859 0.6× 1.8k 1.7× 806 0.9× 190 9.3k
Valériane Leroy 5.3k 1.1× 2.9k 0.8× 2.1k 1.5× 2.0k 1.9× 470 0.5× 283 7.8k
Shabbar Jaffar 4.1k 0.8× 4.3k 1.2× 1.0k 0.7× 1.2k 1.2× 2.0k 2.2× 178 9.7k
Curtis Cooper 4.4k 0.9× 4.9k 1.4× 1.4k 1.0× 1.0k 1.0× 563 0.6× 356 9.2k

Countries citing papers authored by Meg Doherty

Since Specialization
Citations

This map shows the geographic impact of Meg Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meg Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meg Doherty more than expected).

Fields of papers citing papers by Meg Doherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meg Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meg Doherty. The network helps show where Meg Doherty may publish in the future.

Co-authorship network of co-authors of Meg Doherty

This figure shows the co-authorship network connecting the top 25 collaborators of Meg Doherty. A scholar is included among the top collaborators of Meg Doherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meg Doherty. Meg Doherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schalkwyk, Cari van, Gesine Meyer‐Rath, Lise Jamieson, et al.. (2025). Cost-effectiveness of different HPV vaccination strategies for cervical cancer prevention in South Africa. Vaccine. 64. 127770–127770.
2.
Jarvis, Joseph N, Peter Ehrenkranz, David S. Lawrence, et al.. (2025). Reducing HIV incidence and mortality: two sides of the same coin in the approach to ending AIDS. The Lancet HIV. 13(3). e207–e212.
3.
Inzaule, Seth, Ronaldo Silva, Nathan Ford, et al.. (2025). Comparative analyses of COVID-19 in-hospital mortality in people with HIV during SARS-CoV-2 pre-Delta, Delta, and Omicron waves. AIDS. 39(14). 2114–2122. 1 indexed citations
4.
Prochazka, Mateo, Ana Hoxha, Antons Mozalevskis, et al.. (2024). Temporary adaptations to sexual behaviour during the mpox outbreak in 23 countries in Europe and the Americas: findings from a retrospective cross-sectional online survey. The Lancet Infectious Diseases. 24(12). 1309–1318. 7 indexed citations
5.
Easterbrook, Philippa, et al.. (2024). WHO 2024 hepatitis B guidelines: an opportunity to transform care. ˜The œLancet. Gastroenterology & hepatology. 9(6). 493–495. 29 indexed citations
6.
Baggaley, Rachel, et al.. (2023). Role of viral suppression in HIV treatment and prevention and its potential in addressing harmful laws and discrimination. Sexual Health. 20(3). 181–185. 1 indexed citations
7.
Penazzato, Martina, Clare Flanagan, Elaine J. Abrams, et al.. (2022). Prevalence of undiagnosed HIV among children in South Africa, Côte d'Ivoire and Zimbabwe: a model‐based analysis to inform paediatric HIV screening programmes. Journal of the International AIDS Society. 25(12). e26045–e26045. 5 indexed citations
8.
Renaud, Françoise, Lynne Mofenson, Helen Dolk, et al.. (2022). Surveillance of ARV safety in pregnancy and breastfeeding: towards a new framework. Journal of the International AIDS Society. 25(S2). e25922–e25922. 10 indexed citations
9.
Vojnov, Lara, Sergio Carmona, Clement Zeh, et al.. (2022). The performance of using dried blood spot specimens for HIV-1 viral load testing: A systematic review and meta-analysis. PLoS Medicine. 19(8). e1004076–e1004076. 21 indexed citations
10.
Ford, Nathan, Marco Vitória, Ajay Rangaraj, et al.. (2020). Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment. Journal of the International AIDS Society. 23(4). e25489–e25489. 108 indexed citations
11.
12.
Mofenson, Lynne, Anton Pozniak, Elliot Raizes, et al.. (2019). Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects. Journal of the International AIDS Society. 22(7). e25352–e25352. 30 indexed citations
13.
Vitória, Marco, Andrew Hill, Nathan Ford, et al.. (2018). The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries. AIDS. 32(12). 1551–1561. 76 indexed citations
14.
Rollins, Nigel, et al.. (2017). Improving Retention in Care Among Pregnant Women and Mothers Living With HIV: Lessons From INSPIRE and Implications for Future WHO Guidance and Monitoring. JAIDS Journal of Acquired Immune Deficiency Syndromes. 75(2). S111–S114. 19 indexed citations
15.
Rutstein, Sarah E., Jintanat Ananworanich, Sarah Fidler, et al.. (2017). Clinical and public health implications of acute and early HIV detection and treatment: a scoping review. Journal of the International AIDS Society. 20(1). 21579–21579. 100 indexed citations
16.
Tucker, Joseph D., Lai Sze Tso, Brian J. Hall, et al.. (2017). Enhancing Public Health HIV Interventions: A Qualitative Meta-Synthesis and Systematic Review of Studies to Improve Linkage to Care, Adherence, and Retention. EBioMedicine. 17. 163–171. 38 indexed citations
17.
Waldrop, Greer, Meg Doherty, Marco Vitória, & Nathan Ford. (2016). Stable patients and patients with advanced disease: consensus definitions to support sustained scale up of antiretroviral therapy. Tropical Medicine & International Health. 21(9). 1124–1130. 47 indexed citations
18.
Shubber, Zara, Edward J. Mills, Jean B. Nachega, et al.. (2016). Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis. PLoS Medicine. 13(11). e1002183–e1002183. 353 indexed citations breakdown →
19.
Odeny, Thomas, Nancy Padian, Meg Doherty, et al.. (2015). Definitions of implementation science in HIV/AIDS. The Lancet HIV. 2(5). e178–e180. 43 indexed citations
20.
Latkin, Carl A., Wallace Mandell, Amy R. Knowlton, et al.. (1998). Gender Differences in Injection-Related Behaviors Among Injection Drug Users in Baltimore, Maryland. AIDS Education and Prevention. 10(3). 257–263. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce R. Schackman Breakdown of academic impact, for papers by Gregory M. Lucas Breakdown of academic impact, for papers by Kelly A. Gebo Breakdown of academic impact, for papers by Carlo Giaquinto Breakdown of academic impact, for papers by Alison D. Grant Breakdown of academic impact, for papers by Nathan Ford Breakdown of academic impact, for papers by Eli S. Rosenberg Breakdown of academic impact, for papers by Valériane Leroy Breakdown of academic impact, for papers by Shabbar Jaffar Breakdown of academic impact, for papers by Curtis Cooper
Rankless by CCL
2026